KaplanB.S., DrummondK.N.The hemolytic-uremic syndrome is a syndrome. N Engl J Med1978; 298: 964–6.
2.
RossiE.C., CaroneF.A., Del GrecoF.Hemolytic-uremic syndrome and platelet-endothelial interactions. In: RemuzziG., MeccaG., de GaetanoG. (eds.). Hemostasis, Prostaglandins and Renal Disease.New York: Raven Press, 1980, 321–9.
3.
ByrnesJ.J., KhuranaM.Treatment of thrombotic thrombocytopenic purpura with plasma. N Engl J Med1977; 297: 1386–9.
4.
MisianiR., AppianiA.C., EdefontiA.Haemolytic uraemic syndrome: therapeutic effect of plasma infusion. Br Med J1982; 285: 1304–6.
5.
HongS.C.L., Polsky-CynkinR., LevineL.Stimulation of prostaglandin biosynthesis by vasoactive substances in methylcholanthrene-transformed mouse BALB/3T3. J Biol Chem1976; 251: 776–80.
6.
HongS.L.Effect of bradykinin and thrombin on prostacyclin synthesis in endothelial cells from calf and pig aorta and from human umbilical vein. Thromb Res1980; 18: 787–95.
7.
HopeW., MartinT.J., ChestermanC.N., MorganF.J.Human β-thromboglobulin inhibits PGI2 production and binds to a specific site in bovine aortic endothelial cells. Nature1979; 282: 210–2.
8.
FleisherL.N., TallA.R., WitteL.D., MillerR.W., CannonP.J.Stimulation of arterial endothelial cell prostacyclin synthesis by high density lipoproteins. J Biol Chem1982; 257: 6653–5.
9.
MacIntyreD.E., PearsonJ.D., GordonJ.L.Localisation and stimulation of prostacyclin production in vascular cells. Nature (London)1978; 271: 549–51.
RemuzziG., MeccaG., LivioM.Prostacyclin generation by cultured endothelial cells in haemolytic uraemic syndrome. Lancet1980; 1: 656–7.
12.
JorgensenK.A., PedersenR.S.Familial deficiency of prostacyclin production stimulating factor in the hemolytic uremic syndrome of childhood. Thromb Res1981; 21: 311–5.
13.
RemuzziG., MarchesiD., MisianiR., MeccaG., de GaetanoG., DonatiM.B.Familial deficiency of a plasma factor stimulating vascular prostacyclin activity. Thromb Res1979; 16: 517–25.
14.
DonatiM.B., MisianiR., MarchesiD.Hemolytic-uremic syndrome, prostaglandins and plasma factors. In: RemuzziG., MeccaG., De GaetanoG. (eds.). Hemostasis, Prostaglandins and Renal Disease.New York: Raven Press, 1980; 283–90.
15.
DefreynG., ProesmansW., MachinS.J., LemmensF., VermylenJ.Abnormal prostacyclin metabolism in the hemolytic uremic syndrome: equivocal effect of prostacyclin infusions. Clin Nephrol1982; 18: 43–9.
16.
StuartM.J., SpitzerR.E., CoppeD.Abnormal platelet and vascular prostaglandin synthesis in an infant with hemolytic uremic syndrome. Pediatrics1983; 71: 120–4.
17.
DeckmynH., ZojaC., ArnoutJ.Partial isolation and function of the prostacyclin regulating plasma factor. Clinical Science1985; 69: 383–93.
18.
FurstP., ZimmermanL., BergstromJ.Determination of endogenous middle molecules in normal and uremic body fluids. Clin Nephrol1976; 5: 178–88.
19.
RemuzziG., LivioM., CavenaghiA.E.Unbalanced prostaglandin synthesis and plasma factors in uraemic bleeding. A hypothesis. Thromb Res1978; 13: 531–6.
20.
BeattieT.J., MurphyA.V., WilloughbyM.L.N., BelchJ.J.F.Prostacyclin infusion in haemolytic-uraemic syndrome of children. Br Med J1981; 283: 470.
SegerR., JollerP., BaerlocherK., HitzigW.H.Neuramini-dase-produzierende Pneumokokken in der Pathogenese-des hamolytisch-uramischen Syndroms. Schweit Med Wochenschr1980; 110: 1454–6.